Back to search

Article

From Bench to Bedside: A Meta-Analysis of Translational Research in Duchenne Muscular Dystrophy

2025-07-07

Abstract excerpt

<h4>Background: </h4> Duchenne muscular dystrophy (DMD) is a severe genetic disorder caused by mutations in the DMD gene, leading to progressive muscle degeneration. Translational research bridges preclinical discoveries and clinical applications, driving the development of novel therapies. Evaluating the effectiveness of this process is essential to guide future advancements.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f85b4b94-10a6-5777-8d18-e550397ea423
DOI
10.22541/au.175191869.97372473/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
From Bench to Bedside: A Meta-Analysis of Translational Research in Duchenne Muscular DystrophyDOI 10.22541/au.175191869.97372473/v1
Drug development progress in duchenne muscular dystrophySemantic proximity
New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.Semantic proximity
[Clinical practice guidelines for Duchenne muscular dystrophy].Semantic proximity
Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity
An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.Semantic proximity
Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’Semantic proximity
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments.Semantic proximity
Muscular dystrophy: new challenges and review of the current clinical trials.Semantic proximity
Comprehensive analysis of 2097 Patients with Dystrophinopathy Based on a Database From 2011 to 2021Semantic proximity
Challenges of clinical trial design for DMD.Semantic proximity
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular DystrophySemantic proximity
Emerging therapeutic strategies in muscular dystrophy: an updated review on pathogenesis and treatment advances.Semantic proximity
Select a neighboring publication to make it the new centre.